Smart Devices to ‘Revolutionize’ Treatment, says CPhI Award Winner

Biocorp, a developer of connected devices, has been recognized in CPhI’s annual Pharma Awards announced during CPhI Worldwide. Honored in the "IT, mHealth, and Digitalization" category, Biocorp offers technologies such as Inspair (an intelligent sensor that transforms a conventional inhaler into a connected device) and DataPen (reusable and communicating pen injector).Eric Dessertenne, deputy chief officer of Biocorp, tells MD+DI that connected health “will be a new way to treat patients with more direct contacts between patients and healthcare professionals. It will also provide an incredible source of information for the pharma company about how their device and their drug is being used by the patient. And ultimately it will improve the adherence rate of the patients and their clinical outcomes.”Some connected devices are already on the market, he says, “but the biggest move will come in the next couple of years. Processes in pharma are by nature very long, and dealing with smart devices is pretty new for pharma; but the story is already written—smart devices will revolutionize the way patients are being treated.”There could be some regulatory challenges, but Dessertenne says that European and U.S. agencies are working towards a simplification of the regulatory path for most smart devices. “FDA set up a specific department to deal with such questions,” he says, pointing to this program. Regarding any potential challenges in acceptance of smart devices, he ...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Source Type: news